Combined tDCS and Cognitive Training for Opioid Use Disorder

This study is looking into whether adding Transcranial Direct Current Stimulation (tDCS) and cognitive training can help people who are already taking medication for Opioid Use Disorder (OUD). tDCS is a device that delivers a small electrical current to a specific part of the brain. Researchers want to see if this combination helps improve brain networks related to reward and decision-making, and also executive functioning (skills like planning and problem-solving). You might be able to join if you are 18 or older, have OUD, are currently on OUD medication, and can follow study procedures. The study aims to enroll 40 participants.

Study design
This interventional study plans to enroll 40 participants. It is not specified if it is randomized or blinded.
What's involved
Participants will receive 30-minute tDCS stimulation sessions. The study measures effects immediately after the intervention.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints are measured immediately after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07158853

Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

Recruiting
PHASE1Ages 18+InterventionalTreatment
University of Minnesota
~40 participants
Updated 2026-07-06 on ClinicalTrials.gov
What's tested:Transcranial Direct Current Stimulation (tDCS)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
tDCS effect on circuit-based target engagement of a prefrontal-incentive salience network
Measured over immediately after the intervention
+1 more outcome measured
Opioid Use Disorder
1 sites across 1 states
Minnesota1
  • Jazmin Camchong, PhD · PRINCIPAL_INVESTIGATOR · University of Minnesota

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ability to provide consent and comply with study procedures
Diagnostic and Statistical Manual of Mental Disorders criteria for OUD
Undergoing medication treatment for OUD. Participants may have current comorbid drug use, but primary diagnosis must be OUD
Intention to remain in the study until intervention completion.

Exclusion

Any medical condition with neurological sequelae
Head injury resulting in skull fracture or loss of consciousness of \>30 minutes
Any tDCS or MRI contraindication (tDCS: history of seizures, metallic cranial plates/screws or implanted device, history of eczema on scalp. MRI: unapproved metallic implants, pacemakers or any other implanted electrical device, shrapnel, metallic braces, non-removable body piercings, pregnancy, breathing or movement disorder, or claustrophobia)
Any psychotic disorder (participants with other treated and stable psychiatric disorders will be included)
Presence of a condition that would render study measures impossible to administer or interpret
Age younger than 18
Primary current substance use disorder on a substance other than opioids except for caffeine or nicotine
In treatment instead of jail
Pregnancy
Disrespectful behavior towards the investigators and staff.
  • tDCS effect on circuit-based target engagement of a prefrontal-incentive salience networkimmediately after the intervention

    To assess changes in target engagement, we will measure the change in resting-state functional connectivity (measured as a Pearson correlation coefficient, r) between the prefrontal cortex and the incentive salience network from pre- to post-intervention using a paired t-test. The connectivity metric ranges from a minimum value of -1.0 (perfectly negative correlation) to a maximum value of 1.0 (perfectly positive correlation). Higher scores indicate stronger functional connectivity (greater top-down regulation), representing a better outcome.

  • tDCS effect on executive functioningimmediately after the intervention

    To assess changes in executive functioning, we will measure the change in executive functioning from pre- to post-intervention using a repeated measures t-test. Cognitive performance will be assessed via a behavioral battery spanning cognitive flexibility, working memory, inhibitory control, and delay discounting (utilizing standardized Pearson assessments and a computerized delay discounting task). Performance metrics across tasks will be converted to standardized z-scores (typically ranging from -3.0 to +3.0). The primary endpoint is the post-intervention mean z-score minus the pre-intervention mean z-score. A positive change score indicates an increase in executive functioning, representing a better clinical outcome.